Silvia Lanfranconi

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 177 citations · Full text

Brain Atrophy and Cerebral Small Vessel Disease

Arani Nitkunan, Silvia Lanfranconi, Rebecca A. Charlton et al. · Stroke · 2010 · 134 citations · Full text

Migraine in cervical artery dissection and ischemic stroke patients

Tiina M. Metso, Turgut Tatlisumak, Stéphanie Debette et al. · Neurology · 2012 · 98 citations

Inclusion body myopathy and frontotemporal dementia caused by a novel VCP mutation

Anna Bersano, Roberto Del Bo, Costanza Lamperti et al. · Neurobiology of Aging · 2007 · 71 citations

Alzheimer's Disease, Mendelian Disorder, Inclusion Body Myopathy +12

Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial

Silvia Lanfranconi, Elisa Scola, Jennifer Meessen et al. · The Lancet Neurology · 2022 · 56 citations · Full text

Neuro-oncology, Pilot Trial, Vascular Malformation +5